PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.).\', \'Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, Toronto, Ontario, Canada (Q.H.).\', \'Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (R.S., A.G.).\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.7326/M21-3480
?:doi
?:hasPublicationType
?:journal
  • Annals of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 34807716
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.466
?:rankingScore_hIndex
  • 349
?:title
  • Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34807716>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34807716>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all